Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis

NCT04203875 is registered in ClinicalTrials.gov with Stuart Knechtle, M.D. as lead sponsor.

NCT NCT04203875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04203875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
Lead sponsor
Stuart Knechtle, M.D.
Phase
Phase 1
Overall status
Terminated
Start date
March 9, 2020
Completion date
July 23, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hepatitis